Human health sciences: Multidisciplinary, general & others
Author, co-author :
De Tullio, Pascal ; Université de Liège - ULiège > CIRM > metabolomics group
Leenders, Justine ; Université de Liège - ULiège > CIRM > metabolomics group
Vega de Ceniga, Melina; Hospital de Galdakao-Usansolo > angiologie and vascular surgery
Chakfé, Nabil; University Hospital of Strasbourg > Vascular Surgery
Kolh, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.
Language :
English
Title :
Metabolomics as an Innovative Tool for a Personalised Approach to Vascular Disease
Publication date :
March 2019
Journal title :
European Journal of Vascular and Endovascular Surgery
Food and Drug Administration, Paving the Way for Personalized Medicine: FDA's Role in a New Era of Medical Product Development. 2014, 1–74 https://www.fdanews.com/ext/resources/files/10/10-28-13-Personalized-Medicine.pdf.
Personalized Medicine Coalition, Personalized Medicine at FDA: 2017 Progress Report., 2018, 1–10 http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/PM_at_FDA_2017_Progress_Report.pdf.
Bates, S., Progress towards personalized medicine. Drug Discov Today 15 (2010), 115–120.
Pirmohamed, M., Personalized pharmacogenomics: predicting efficacy and adverse drug reaction. Annu Rev Genomics Hum Genet 15 (2014), 349–370.
Chen, R., Snyder, M., Promise of personalized omics to precision medicine. Wiley Interdiscip Rev Syst Biol Med 5 (2013), 73–82.
Patti, G.J., Yanes, O., Siuzdak, G., Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13 (2012), 263–269.
Astarita, G., Langridge, J., An emerging role for metabolomics in nutrition science. J Nutrigene Nutrigenomics 6 (2013), 181–200.
Kim, H.K., Choi, Y.H., Verpoorte, R., NMR-based plant metabolomics: where do we stand, where do we go?. Trends Biotechnol 29 (2011), 267–275.
Tomita, M., Kami, K., Cancer. Systems biology, metabolomics, and cancer metabolism. Science 336 (2012), 990–991.
Frederich, M., Pirotte, B., Fillet, M., de Tullio, P., Metabolomics as a challenging approach for medicinal chemistry and personalized medicine. J Med Chem 59 (2016), 8649–8666.
Everett, J., NMR-based pharmacometabolomics: a new paradigm for personalized or precision medicine. Prog Nucl Magn Reson Spectro 102–103 (2017), 1–14.
Turer, A.T., Using Metabolomics to assess myocardial metabolism and energetics in heart failure. J Mol Cell Cardiol 55 (2013), 12–18.
Kordalewska, M., Markuszewski, M.J., Metabolomics in cardiovascular diseases. J Pham Biomed Anal 113 (2015), 121–136.
Ussher, J., Elmariah, S., Gerszten, R.E., Dyck, J.R.B., The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease. J Am Col Cardiol 68 (2016), 2850–2870.
Vorkas, P.A., Shalhoub, J., Lewis, M.R., Spagou, K., Want, E.J., Nichloson, J.K., et al. Metabolic phenotype of carotid atheroslerotic plaques relate to stroke risk: an exploratory study. Eur J Vasc Endovasc Surg 52 (2016), 5–10.
Cheng, S., Shah, S.H., Corwin, E.J., Fiehn, O., Fitzerald, R.L., Gertzen, R.E., et al. Potential impact and study considerations of metabolomics in cardiovascular health and disease: a scientific statement from the American heart association. Circ Cardiovasc Genet 10 (2017), e1–e13.
Zhou, X., Wang, R., Zhang, T., Liu, F., Zhang, W., Wang, G., et al. Identification of lysophosphatidylcholines and sphingolipids as potential biomarkers for acute aortic dissection via serum metabolomics. Eur J Vasc Endovasc Surg 57 (2019), 434–441.
Kolh, P., Dick, F., Halliday, A., EJVES: the leading journal in vascular surgery, and one of many highlights for the ESVS annual meeting in Valencia. Eur J Vasc Endovasc Surg 56 (2018), 315–317.
